BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25992884)

  • 1. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.
    Blanco-Prieto S; Vázquez-Iglesias L; Rodríguez-Girondo M; Barcia-Castro L; Fernández-Villar A; Botana-Rial MI; Rodríguez-Berrocal FJ; de la Cadena MP
    PLoS One; 2015; 10(5):e0127318. PubMed ID: 25992884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units.
    Blanco-Prieto S; De Chiara L; Rodríguez-Girondo M; Vázquez-Iglesias L; Rodríguez-Berrocal FJ; Fernández-Villar A; Botana-Rial MI; de la Cadena MP
    Sci Rep; 2017 Jan; 7():41151. PubMed ID: 28117344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-analyte serum test for the detection of non-small cell lung cancer.
    Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
    Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarker profiles as diagnostic tools in lung cancer.
    Nolen BM; Langmead CJ; Choi S; Lomakin A; Marrangoni A; Bigbee WL; Weissfeld JL; Wilson DO; Dacic S; Siegfried JM; Lokshin AE
    Cancer Biomark; 2011-2012; 10(1):3-12. PubMed ID: 22297547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.
    Otero-Estévez O; De Chiara L; Rodríguez-Berrocal FJ; Páez de la Cadena M; Cubiella J; Castro I; Gonzalez-Mao C; Hernandez V; Martínez-Zorzano VS
    Br J Cancer; 2015 Jan; 112(2):375-81. PubMed ID: 25461801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
    PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA; Basu S; Faber LP; Kim AW; Coon JS; Kaiser-Walters KA; Fhied C; Thomas S; Rouhi O; Warren WH; Bonomi P; Liptay MJ
    J Thorac Oncol; 2009 Mar; 4(3):338-47. PubMed ID: 19190517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.
    Lococo F; Paci M; Rapicetta C; Rossi T; Sancisi V; Braglia L; Cavuto S; Bisagni A; Bongarzone I; Noonan DM; Albini A; Maramotti S
    Int J Mol Sci; 2015 Aug; 16(8):19612-30. PubMed ID: 26295387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.
    Zhao W; Yu H; Han Z; Gao N; Xue J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(8):9506-11. PubMed ID: 26464712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages.
    Chian CF; Hwang YT; Terng HJ; Lee SC; Chao TY; Chang H; Ho CL; Wu YY; Perng WC
    Oncotarget; 2016 Aug; 7(31):50582-50595. PubMed ID: 27418131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
    Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
    Xu C; Yu LK; Zhang X
    Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
    Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
    Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
    Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
    J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.
    Lemos-González Y; Rodríguez-Berrocal FJ; Cordero OJ; Gómez C; Páez de la Cadena M
    Br J Cancer; 2007 May; 96(10):1569-78. PubMed ID: 17453000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.